R&D News | pharmaphorum

News

Cancer vaccines come to the fore at AACR

This year’s American Association of Cancer Research (AACR) annual meeting saw a clutch of new studies on therapeutic vaccines that suggest the approach is starting to gain

News

GSK bolsters respiratory pipeline with Bellus Health buy

GSK has agreed to acquire Canada’s Bellus Health for around $2 billion, bolting on a late-stage drug candidate for chronic refractory cough.

News

Call for ‘more trial, less error’ in study diversity

A report from a UK think tank focused on the impact of longevity on society has found that people aged over 60 are still poorly represented in clinical trials – even thoug

News

Regeneron chair Vagelos steps down at 93

Biopharma legend P. Roy Vagelos will step down as chairman of Regeneron Pharmaceuticals after 29 years in June, at the age of 93.

News

Complement raises €72m for geographic atrophy gene therapy

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing

News

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna and partner Merck & Co have fleshed out the data from their clinical trial of personalised mRNA vaccine for melanoma, saying the results support the start of a

Cancer vaccines come to the fore at AACR

GSK bolsters respiratory pipeline with Bellus Health buy

Call for ‘more trial, less error’ in study diversity

Regeneron chair Vagelos steps down at 93

Complement raises €72m for geographic atrophy gene therapy

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks